Revive Therapeutics (RVV:TSXV 20 cents / RVVTF:OTCQB)
After the Orphan Drug Status approval this week, RVV cycled great volume in the high 0.20's.... but this trading is seriously messed up.
I don't know if they are planning to announce a financing in this range and those who will participate are dumping stock to fund that. Or are shareholders so tired of this CEO that when rallies fail, they just dump their paper? Its really hard to tell what is wrong with this company.
I know that companies who apply for and get an FDA Orphan Drug designation, are NOT pump and dumps. Especially when they received it on science associated with Cannabis - a schedule 1 drug in the United States. That is not going to happen every day. Fundamentally this is solid - or at least it appears so. BUT it trades horrible !
I am convinced there is really good value near 20 cents and mid next week I will explain why. But go through their corporate presentation. Its neat science and in light of the ongoing frustrations with the way this stock trades, I think RVV offers very attractive risk/reward from this level.
Publicly traded Canadian marijuana stocks are commanding huge valuations and many have a LOT of cash. It would make sense that they start to take more of an interest in the science side of this business and will be looking to acquire companies like Revive (even if its in 2019).
Revive Corporate Presentation: